Cargando…
Prognostic factors in the patients with T2N0M0 colorectal cancer
BACKGROUND: The 5-year survival rate of the patients with stage I colorectal cancer is about 90 %; therefore, adjuvant therapy has not been recommended after radical resection; however, about 16–26 % of T2N0M0 patients will be dead at 5 years despite radical curative resection. It indicated that the...
Autores principales: | Xu, Bin, Yu, Lin, Zhao, Li-Zhong, Ma, Dong-Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785652/ https://www.ncbi.nlm.nih.gov/pubmed/26965721 http://dx.doi.org/10.1186/s12957-016-0826-4 |
Ejemplares similares
-
Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods
por: Wang, Guanyu, et al.
Publicado: (2020) -
Prognostic factors of T2aN0M0 (T3‐4cmN0M0, stage IB) non‐small‐cell lung cancer after surgery: Single‐center real‐world research
por: Liu, Lei, et al.
Publicado: (2021) -
Prognostic Value of Microvascular Density in Dukes A and B (T1–T4, N0, M0) Colorectal Carcinomas
por: Uribarrena A, Rafael, et al.
Publicado: (2009) -
Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer
por: Xu, Ning, et al.
Publicado: (2020) -
Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI
por: Li, Shihong, et al.
Publicado: (2017)